IGC Pharma Inc (AMEX: IGC) has seen a decline in its stock price by -9.16 in relation to its previous close of 0.49. However, the company has experienced a 1.34% gain in its stock price over the last five trading sessions. Accesswire reported 2023-04-18 that POTOMAC, MD / ACCESSWIRE / April 18, 2023 / IGC Pharma, Inc. (NYSE American:IGC) today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023, at 4:30 PM (Local Time -PDT). Ram Mukunda, Chief Executive Officer, and Claudia Grimaldi, Principal Financial Officer, will be hosting the presentation and answering questions at the conclusion.
Is It Worth Investing in IGC Pharma Inc (AMEX: IGC) Right Now?
The 36-month beta value for IGC is at 1.64. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for IGC is 59.49M, and currently, shorts hold a 1.58% of that float. The average trading volume for IGC on April 23, 2024 was 952.27K shares.
IGC’s Market Performance
IGC’s stock has seen a 1.34% increase for the week, with a 30.91% rise in the past month and a 66.39% gain in the past quarter. The volatility ratio for the week is 26.18%, and the volatility levels for the past 30 days are at 20.72% for IGC Pharma Inc The simple moving average for the last 20 days is -12.27% for IGC stock, with a simple moving average of 29.98% for the last 200 days.
IGC Trading at 12.18% from the 50-Day Moving Average
After a stumble in the market that brought IGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.08% of loss for the given period.
Volatility was left at 20.72%, however, over the last 30 days, the volatility rate increased by 26.18%, as shares surge +18.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +54.12% upper at present.
During the last 5 trading sessions, IGC rose by +1.34%, which changed the moving average for the period of 200-days by +33.18% in comparison to the 20-day moving average, which settled at $0.5108. In addition, IGC Pharma Inc saw 58.91% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IGC
Current profitability levels for the company are sitting at:
- -9.59 for the present operating margin
- 0.4 for the gross margin
The net margin for IGC Pharma Inc stands at -11.62. The total capital return value is set at -1.25. Equity return is now at value -103.36, with -90.30 for asset returns.
Based on IGC Pharma Inc (IGC), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -23.36. The debt to equity ratio resting at 0.03. The interest coverage ratio of the stock is 1296.33.
Currently, EBITDA for the company is -10.91 million with net debt to EBITDA at 0.09. When we switch over and look at the enterprise to sales, we see a ratio of 23.54. The receivables turnover for the company is 13.22for trailing twelve months and the total asset turnover is 0.11. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.85.
Conclusion
In conclusion, IGC Pharma Inc (IGC) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
